A real-world study gives the edge to Eli Lilly’s weight-loss drug, Amazon faces a potential antitrust hurdle in iRobot deal, and other news to start your day.
The Fed Won’t Talk About Rate Cuts. Why Traders Are Betting on Them.
2023-11-28 19:45
A real-world study gives the edge to Eli Lilly’s weight-loss drug, Amazon faces a potential antitrust hurdle in iRobot deal, and other news to start your day.
You Might Like...
Get a lifetime license to Microsoft Office for under £40
Elon Musk’s Neuralink brain chip company says it now has FDA approval for human testing
Tristan Tate hails 'JRE' podcast featuring Patrick Bet-David, fans say 'get your popcorn ready folks'
Factbox-Why does the US want to ban TikTok? The allegations against it
What Happened to Apex Legends Mobile?
We’ve found a PS5 deal in the Amazon Prime Day sale, and it’s sure to sell out
LEGO Launches a New Line of Braille Bricks
Soon, you'll have to pay to DM people who don't follow you on Twitter